These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 28367520)

  • 1. Therapeutic targets of renin-angiotensin system in ocular disorders.
    Choudhary R; Kapoor MS; Singh A; Bodakhe SH
    J Curr Ophthalmol; 2017 Mar; 29(1):7-16. PubMed ID: 28367520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lifestyle-related diseases and anti-aging ophthalmology: suppression of retinal and choroidal pathologies by inhibiting renin-angiotensin system and inflammation].
    Ishida S
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):403-22; discussion 423. PubMed ID: 19348185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Pro)renin receptor: Involvement in diabetic retinopathy and development of molecular targeted therapy.
    Kanda A; Ishida S
    J Diabetes Investig; 2019 Jan; 10(1):6-17. PubMed ID: 29575757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four decades of ocular renin-angiotensin and kallikrein-kinin systems (1977-2017).
    Igić R
    Exp Eye Res; 2018 Jan; 166():74-83. PubMed ID: 28549900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy.
    Wilkinson-Berka JL; Fletcher EL
    Curr Pharm Des; 2004; 10(27):3313-30. PubMed ID: 15544518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and retinal vascular disorders: role of the renin-angiotensin system.
    Wilkinson-Berka JL
    Expert Rev Mol Med; 2004 Jul; 6(15):1-18. PubMed ID: 15387897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-associated prorenin system contributes to development of inflammation and angiogenesis in proliferative diabetic retinopathy.
    Kanda A; Ishida S
    Inflamm Regen; 2016; 36():22. PubMed ID: 29259695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies.
    Moravski CJ; Skinner SL; Stubbs AJ; Sarlos S; Kelly DJ; Cooper ME; Gilbert RE; Wilkinson-Berka JL
    Am J Pathol; 2003 Jan; 162(1):151-60. PubMed ID: 12507898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(Pro) renin receptor in the pathogenesis of proliferative diabetic retinopathy].
    Kanda A
    Nippon Ganka Gakkai Zasshi; 2014 Nov; 118(11):916-26. PubMed ID: 25543383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma.
    Ishizuka ET; Kanda A; Shinmei Y; Ohguchi T; Tagawa Y; Hase K; Yamamoto T; Noda K; Chin S; Ishida S
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32707887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aliskiren inhibits the renin-angiotensin system in retinal pigment epithelium cells.
    Simão S; Santos DF; Silva GA
    Eur J Pharm Sci; 2016 Sep; 92():22-7. PubMed ID: 27343695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological therapy of age-related macular degeneration based on etiopathogenesis].
    Fischer T
    Orv Hetil; 2015 Nov; 156(46):1847-58. PubMed ID: 26548469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men.
    Bukowska A; Spiller L; Wolke C; Lendeckel U; Weinert S; Hoffmann J; Bornfleth P; Kutschka I; Gardemann A; Isermann B; Goette A
    Exp Biol Med (Maywood); 2017 Aug; 242(14):1412-1423. PubMed ID: 28661206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ocular renin-angiotensin system: a therapeutic target for the treatment of ocular disease.
    Giese MJ; Speth RC
    Pharmacol Ther; 2014 Apr; 142(1):11-32. PubMed ID: 24287313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of diabetic retinopathy and the renin-angiotensin system.
    Funatsu H; Yamashita H
    Ophthalmic Physiol Opt; 2003 Nov; 23(6):495-501. PubMed ID: 14622351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor.
    Liu Y; Kanda A; Wu D; Ishizuka ET; Kase S; Noda K; Ichihara A; Ishida S
    Mol Ther Nucleic Acids; 2019 Sep; 17():113-125. PubMed ID: 31254924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine ocular tissues.
    Luhtala S; Vaajanen A; Oksala O; Valjakka J; Vapaatalo H
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):23-8. PubMed ID: 19232015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
    Li XC; Zhang J; Zhuo JL
    Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system.
    Wagner J; Jan Danser AH; Derkx FH; de Jong TV; Paul M; Mullins JJ; Schalekamp MA; Ganten D
    Br J Ophthalmol; 1996 Feb; 80(2):159-63. PubMed ID: 8814748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.